Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innoviva (INVA) EBT (2016 - 2025)

Innoviva (INVA) has disclosed EBT for 16 consecutive years, with $97.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT rose 670.58% year-over-year to $97.8 million, compared with a TTM value of $121.3 million through Sep 2025, up 914.02%, and an annual FY2025 reading of $327.1 million, up 1257823.08% over the prior year.
  • EBT was $97.8 million for Q3 2025 at Innoviva, up from $72.6 million in the prior quarter.
  • Across five years, EBT topped out at $286.4 million in Q3 2022 and bottomed at -$39.3 million in Q2 2024.
  • Average EBT over 5 years is $52.1 million, with a median of $41.1 million recorded in 2023.
  • The sharpest move saw EBT crashed 776.64% in 2024, then skyrocketed 670.58% in 2025.
  • Year by year, EBT stood at -$6.0 million in 2021, then tumbled by 70.77% to -$10.3 million in 2022, then soared by 36.31% to -$6.6 million in 2023, then tumbled by 60.22% to -$10.5 million in 2024, then soared by 1028.14% to $97.8 million in 2025.
  • Business Quant data shows EBT for INVA at $97.8 million in Q3 2025, $72.6 million in Q2 2025, and -$38.6 million in Q1 2025.